iGMDRD397
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Pazopanib | CHEMBL1201733 CHEMBL477772 | 10114000 | DB06589 | Alone | Small Molecule |
Drug Class:
AmidesAngiogenesis InhibitorsAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 SubstratesCytochrome P-450 CYP1A2 SubstratesCytochrome P-450 CYP2D6 InhibitorsCytochrome P-450 CYP2D6 Inhibitors (weak)Cytochrome P-450 CYP3A InhibitorsCytochrome P-450 CYP3A4 InhibitorsCytochrome P-450 CYP3A4 Inhibitors (weak)Cytochrome P-450 Enzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunosuppressive AgentsKinase InhibitorModerate Risk QTc-Prolonging AgentsP-glycoprotein/ABCB1 SubstratesProtein Kinase InhibitorsQTc Prolonging AgentsReceptors, Vascular Endothelial Growth Factor, antagonists & inhibitorsSulfonesSulfur CompoundsUGT1A1 InhibitorsDrug Targets:
FLT1 (P17948)KDR (P35968)FLT4 (P35916)PDGFRA (P16234)PDGFRB (P09619)KIT (P10721)FGFR3 (P22607)ITK (Q08881)FGF1 (P05230)SH2B3 (Q9UQQ2)VEGFRCSF1RDrug Pathways:
RTK signalingDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
2956 | MSH6 | 1 |
8266 | UBL4A | 1 |
2475 | MTOR | 3 |
6598 | SMARCB1 | 1 |
1387 | CREBBP | 1 |
5159 | PDGFRB | 1 |
25937 | WWTR1 | 1 |
3091 | HIF1A | 1 |
2034 | EPAS1 | 1 |
1665 | DHX15 | 1 |
3688 | ITGB1 | 1 |
7428 | VHL | 1 |
6850 | SYK | 2 |
54464 | XRN1 | 1 |
92 | ACVR2A | 1 |
139285 | AMER1 | 1 |
5834 | PYGB | 1 |
7157 | TP53 | 1 |
3791 | KDR | 1 |
2263 | FGFR2 | 2 |
4904 | YBX1 | 1 |
57111 | RAB25 | 1 |
4089 | SMAD4 | 1 |
54658 | UGT1A1 | 1 |
5290 | PIK3CA | 1 |
2113 | ETS1 | 1 |
1869 | E2F1 | 2 |
5925 | RB1 | 1 |
7040 | TGFB1 | 1 |
2261 | FGFR3 | 1 |
4763 | NF1 | 2 |
Gene in drug-gene network: Network Plot
Models in Pazopanib